SMTL ID : 2fw3.1

Crystal structure of rat carnitine palmitoyltransferase 2 in complex with antidiabetic drug ST1326

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x BUI: (3R)-3-{[(TETRADECYLAMINO)CARBONYL]AMINO}-4-(TRIMETHYLAMMONIO)BUTANOATE(Non-covalent)

BUI.1: 20 residues within 4Å: Chain A: W.111, P.128, H.367, Q.442, Y.481, S.483, T.494, S.583, T.584, S.585, L.587, S.593, L.594, G.595, F.597, V.600, A.608, Y.609, G.617, C.618 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:P.128, A:A.608 Hydrogen bonds: A:Y.115, A:H.367, A:H.367, A:Y.481, A:S.585 pi-Cation interactions: A:F.597

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rufer, A.C. et al., The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment. Structure (2006)

Release Date

2007-02-01

Peptides

Carnitine O-palmitoyltransferase II, mitochondrial: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carnitine O-palmitoyltransferase II, mitochondrial

Related Entries With Identical Sequence